logo

High-Throughput Screening Service

Welcome to CD ComputaBio's High-Throughput Screening Service, where we leverage cutting-edge AI methods to enhance drug discovery, biological research, and chemical analysis. With our state-of-the-art technologies and comprehensive approach, we can significantly accelerate your research timelines while maintaining the highest standards of precision and accuracy.

Introduction to High-Throughput Screening

High-throughput screening (HTS) is a method used to quickly conduct millions of chemicals, genetic, or pharmacological tests. Through automation, HTS enables researchers to identify active compounds, antibodies, or genes that elicit a particular biological response. With the incorporation of AI, HTS is not only faster but also smarter, allowing you to derive insights and make informed decisions about your projects.

Our Services

At CD ComputaBio, we employ advanced AI methods to transform drug discovery, biological research, and chemical analysis. Our cutting-edge technologies and thorough approach ensure accelerated research timelines with top-tier precision and accuracy.

Target identification service

Target Identification

We have a subset of target libraries containing pharmacologically well-characterized targets in the most common classes (GPCRs, ion channels, kinase, nuclear receptors, etc.).

Compound screening

Compound Library Screening

We house an extensive collection of diverse chemical compounds and biologics. Our compound library screening service allows you to evaluate thousands of potential drug candidates against specific biological targets in a matter of days.

Virtual screening

Virtual Library Screening

Utilizing in silico methods to predict how compounds will interact with target proteins before experimental validation. Detailed analysis of ligand-target interactions to optimize lead candidates based on binding affinities.

Secondary screening

Secondary Screening and Characterization

  • Assay Confirmation - Implementing secondary assays to confirm hits found in primary screening.
  • Mechanistic Studies - Investigating the mode of action of identified compounds to elucidate their biological effects.

Sample Requirements

Small Molecules Crystalline or liquid samples must be pure and provided in appropriate concentrations.
Biological Samples Protein extracts, cell lysates, or tissue homogenates should be characterized and compatible with the selected assay.
Nucleic Acids RNA, DNA, or plasmids must be of high quality and concentration.

Our High-Throughput Screening Workflow

  • Phase 1: Compound library preparation
    We have various compound libraries and use AI technology to optimize compound structures and space.
  • Phase 2: Screening execution
    During the screening process, we use real-time monitoring to ensure the integrity and accuracy of the detection.
  • Phase 3: Data analysis and AI integration
    • Statistical analysis - We use advanced statistical techniques to verify the results and ensure that only reliable data is provided for review.
    • AI insights - Our AI algorithms synthesize data to identify the most promising leads while gaining insights into the underlying biological mechanisms.

Result Delivery

  • Detailed Reports - You will receive comprehensive reports that include not only the raw data but also insights derived from our AI analyses.
  • Interactive Dashboards -Our integrated dashboards allow you to explore results interactively. You can filter data, visualize trends, and conduct in-depth analyses tailored to your specific research questions.

Our Advantages

Robust Virtual Screening Framework

From single assay development to fully integrated and automated HTS campaigns, we meticulously adapt our services to your specific project requirements.

Expertise and Experience

Our team at CD ComputaBio comprises expert scientists and bioinformaticians experienced in high-throughput screening, drug discovery, and molecular biology.

Flexible Service Packages

From single assay development to fully integrated HTS campaigns, we meticulously adapt our services to cater to your project's specific requirements.

At CD ComputaBio, we offer state-of-the-art HTS services integrated with advanced artificial intelligence (AI) methods. Our platform is designed to accelerate your research while delivering accurate and reproducible results. By leveraging automation and AI, we help identify promising leads that can significantly enhance the efficiency of your drug development efforts. If you are interested in our services or have any questions, please feel free to contact us.

Services

Online Inquiry